Neuro-Oncology Reviews
Volume
27 Number 30
31 October 2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 30, 31 October
Mayr L, Azizi AA, Gojo J, Peyrl A.
Medulloblastoma:
Current Standard of Care and Future Treatment Opportunities.
Paediatr
Drugs. 2025 Oct 21. doi:
10.1007/s40272-025-00726-1. PMID:
41120656. Review. ˍ
Nourizadeh M, Mounesyar SM, Movahhed MS, Alipour K, Zekavatbakhsh
R, Hoseinzadeh M, Davari S, Amirhooshangi M, Amirhoushangi H,
Hamzehzadeh S.
Current strategies and
novel immunotherapeutic approaches for overcoming immune
resistance in glioblastoma.
Discov
Oncol. 2025 Oct 22;16(1):1952. doi:
10.1007/s12672-025-03807-2. PMID:
41123743. Review. ˍ
Santosh V, Sarkar C, Rao S, Ng HK, Shibahara J, Al-Hussaini M,
Buckland ME, Park SH, Tihan T, Wesseling P, Louis DN, Komori T.
AOSNP-ADAPTR resource level-based
recommendations on practical diagnostic strategies for WHO CNS5
adult-type diffuse gliomas.
Brain
Pathol. 2025 Oct 26:e70046. doi:
10.1111/bpa.70046. PMID:
41139930. Guidelines. ˍ
Kann BH, Vossough A, Brüningk SC, Familiar AM, Aboian M,
Linguraru MG, Yeom KW, Chang SM, Hargrave D, Mirsky D, Storm PB,
Huang RY, Resnick AC, Weller M, Mueller S, Prados M, Peet AC,
Villanueva-Meyer JE, Bakas S, Fangusaro J, Nabavizadeh A,
Kazerooni AF; Response Assessment in Pediatric Neuro-Oncology
(RAPNO) group.
Artificial Intelligence
for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO),
part 1: review of the current state of the art.
Lancet
Oncol. 2025 Oct 27;26(11):e597-e606. doi:
10.1016/S1470-2045(25)00484-X. PMID:
41167227. Review˰
ˍ
Kazerooni AF, Familiar AM, Aboian M, Brüningk SC, Vossough A,
Linguraru MG, Huang RY, Hargrave D, Peet AC, Resnick AC, Storm PB,
Mirsky D, Yeom KW, Weller M, Prados M, Chang SM, Mueller S,
Villanueva-Meyer JE, Bakas S, Fangusaro J, Kann BH, Nabavizadeh A;
Response Assessment in Pediatric Neuro-Oncology (RAPNO) group.
Artificial Intelligence for Response
Assessment in Pediatric Neuro-Oncology (AI-RAPNO), part 2:
challenges, opportunities, and recommendations for clinical
translation.
Lancet
Oncol. 2025 Nov;26(11):e607-e618. doi:
10.1016/S1470-2045(25)00489-9. PMID:
41167228. Review˰
ˍ
Pinzi V, Kotecha R, Sahgal A, Gorgulho A, Jane Lim-Fat M, Levivier
M, Ma L, Paddick I, Regis J, P Sheehan J, Suh JH, Yomo S,
Fariselli L.
International
Stereotactic Radiosurgery Society (ISRS) Practice Guidelines for
Radiosurgery in Recurrent High-Grade Glioma.
Neuro
Oncol. 2025 Oct 27:noaf247. doi:
10.1093/neuonc/noaf247. PMID:
41143546. Guidelines.
ˍ
Krucoff MO.
Surgical decision making
in the era of supramarginal glioma resections: a current
perspective and narrative review.
CNS
Oncol. 2025 Oct 28;14(1):2571341. doi:
10.1080/20450907.2025.2571341. PMID:
41147694. Perspective. ˍ
Shokr H, Liao WC, Faivre-Finn C, Dempsey C, Williams KJ, Chen LC.
Impact of statin use on survival and
adverse events in patients with cancer receiving radiotherapy: a
systematic review and meta-analysis.
BMC
Cancer. 2025 Oct 29;25(1):1666. doi:
10.1186/s12885-025-15038-3. PMID:
41163198. Review; Meta-analysis. ˍ
Abdel-Rasol MA, El-Sayed WM.
Advancing
Medulloblastoma Treatment: Molecular Mechanisms, Drug Repurposing,
and Precision Therapies.
Mol
Diagn Ther. 2025 Oct 31. doi:
10.1007/s40291-025-00817-2. PMID:
41168621. Review. ˍ
Balasubramanian K, Kharbat AF, Yurtluk MD, Call-Orellana F,
Sankarappan K, Downes A, Passias P, Hwang S, Agarwal N, Rajendran
S, Shakir HJ, Burke JF, Jea A, Graffeo CS, Janjua MB.
Spinal
oligodendroglioma: a > 70-year systematic review of current
literature.
J
Neurosurg Spine. 2025 Oct 31:1-12. doi:
10.3171/2025.6.SPINE25425? PMID:
41172367. Review˰
ˍ
Mahdi J, Gust JA, Vitanza NA, Scott B, Monje M, Ronsley R.
Neurotoxicity in central nervous
system tumors treated with CAR T cell therapy: a review.
J
Neurooncol. 2025 Oct 31;176(1):60. doi:
10.1007/s11060-025-05251-2. PMID:
41171480. Review˰
ˍ